← Eichor
Study identifier: NCT05732311 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression

Condition: Depression  ·  Sponsor: Berthold Langguth, MD, Ph.D.

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This is a randomized, multi-center, open-label study in which patients with depression who responded to an open-label treatment with intermittent theta burst stimulation (iTBS) will receive this procedure as maintenance therapy. The patients will be randomized to two study arms. The arms differ in the frequency of stimulation (standard iTBS (5 treatments every working day for one week) vs. accelerated iTBS (5 treatments in one day)). For purposes of effect size estimation an interim analysis will be done after half of the patients.

This description comes directly from the study's public registry record.

Talk to the study team

Martin Schecklmann, Prof.  ·  +49-941-941-2054  ·  martin.schecklmann@medbo.de

Mohamed Abdelnaim, Dr.  ·  +49-941-941-1256  ·  mohamed.abdelnaim@medbo.de

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Psychiatry and Psychotherapy, University of RegensburgRegensburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05732311